Archer-Daniels-Midland Company
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ADM research report →
Range $75 – $95
Price Chart
About the company
Archer-Daniels-Midland Company (ADM) stands as a major global enterprise in the agricultural sector, focused on the sourcing, transportation, storage, processing, and distribution of a wide array of agricultural commodities, finished goods, and essential ingredients. Its expansive operations span numerous countries, including pivotal markets such as the United States, Switzerland, the Cayman Islands, Brazil, Mexico, and the United Kingdom, alongside a broader international presence. ADM's business is strategically organized into three core divisions: Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition.
- CEO
- Juan Ricardo Luciano
- IPO
- 1980
- Employees
- 41,147
- HQ
- Chicago, IL, US
AI snapshot
Six angles, distilled from the data.
ADM remains in a medium-term downtrend after losing its 200-day moving average, with the stock still well below both the 50-day and 200-day lines. The setup is more repair than breakout, though it is also far from the 52-week low, leaving room for a base if momentum stabilizes.
Street sentiment is cautious-to-neutral: consensus sits at Hold, with 12 Buys, 23 Holds, and 1 Sell. The average target is 82.8, above the recent trading level, but the latest move was JPMorgan’s upgrade to Neutral, reinforcing a mixed but not broken outlook.
ADM has been beating more often than missing, with 6 of the last 8 quarters topping estimates and the latest quarter ahead by 8.6%. Next-year EPS is still modeled higher at 5.6523 versus 5.12 TTM, so shareholders should watch whether margin recovery supports that path.
The signal leans constructive, with net buying from a director and no discretionary selling in the recent record. Most of the other activity is award-based director grants, which is routine compensation noise rather than a conviction signal.
Profitability is modest but steady, with a 7.4% gross margin, 2.91% operating margin, and 2.95% net margin. Growth is improving too, with revenue up 9.6% year over year and EPS growth at 6.71%, while free cash flow reached $6.7 billion in fiscal 2025.
ADM screens as a defensive agricultural processor with lower volatility than many industrial peers, supported by a beta of 0.615. Valuation is not stretched at 16.01x earnings, and the market is paying for stable cash generation rather than high growth.
Similar companies
Peers in the same neighborhood.
- Market Cap
- $31.86B
- P/E
- 13.05
- Fwd P/E
- 11.88
- PEG
- 0.12
- P/S
- 0.38
- P/B
- 1.36
- EV/EBITDA
- 8.70
- Div Yield
- 3.11%
- Gross Margin
- 7.44%
- Op Margin
- 3.04%
- Net Margin
- 2.95%
- ROE
- 10.68%
- ROIC
- 5.94%
Latest fiscal year · YoY change
- Revenue
- $80.27B-6.2%
- Gross Profit
- $5.03B-12.9%
- Op Income
- $1.42B
- Net Income
- $1.08B-40.1%
- EPS
- $2.23-39.1%
- OCF Growth
- +95.4%
- FCF Growth
- +242.6%
- 52W High
- $88.75
- 52W Low
- $57.17
- 50D MA
- $78.47
- 200D MA
- $76.74
- Beta
- 0.61
- RSI (14)
- 27
- Avg Volume
- 3.51M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
ADM delivered a strong Q3 with adjusted EPS of $1.77, raised full-year 2026 guidance again, and pointed to continued strength in biofuels and Nutrition momentum.· November 3, 2026
- Adjusted EPS was $1.77 and total segment operating profit was $1.4 billion, with segment profit up 64% year over year.
- ADM raised full-year 2026 adjusted EPS guidance to $5.50-$5.80 from $5.15-$5.60.
- Biofuels-related businesses were a major driver: AS&O operating profit rose to $778 million and Carbohydrate Solutions to $470 million.
- Nutrition revenues fell 4% year over year to $1.8 billion, but operating profit still rose 3% as Flavors and Animal Nutrition improved.
- Management said 2027 should look broadly similar to 2026, with constructive biofuels demand/margins and continued investment in growth platforms.
ADM reported adjusted EPS of $1.77 in Q3 2026 and total segment operating profit of $1.4 billion. Total segment operating profit increased 64% versus the prior-year quarter. AS&O operating profit was $778 million, up 105%, including about $35 million of net positive mark-to-market and timing impacts; Crushing operating profit was $311 million, up about $300 million year over year; Refined Products and Other was $218 million, up 82%; and Wilmar equity earnings were $77 million, up 38%. Carbohydrate Solutions operating profit was $470 million, up 40%; Nutrition revenues were $1.8 billion, down 4%, and Nutrition operating profit was $134 million, up 3%. For the first 9 months, cash flow from operations before working capital was approximately $3 billion. ADM raised 2026 adjusted EPS guidance to $5.50-$5.80 from $5.15-$5.60 and lowered expected 2026 capex to $1.2 billion-$1.3 billion from $1.3 billion-$1.5 billion. The company also raised its net 45Z benefit expectation to approximately $350 million from about $250 million.
Juan Luciano framed the quarter as proof that ADM’s scale in crushing, ethanol and biodiesel is a competitive advantage in a constructive policy and pricing backdrop. He emphasized strong execution, record South American soybean crush volumes, continued Nutrition progress, and the strategic importance of projects like the CJ amino acid JV and precision fermentation. His tone was confident and optimistic, but he also noted volatility remains and said the team is focused on controlling what it can and continuing to invest prudently.
Monish Patolawala highlighted the main financial drivers behind the quarter: favorable North American biofuels margins, stronger ethanol margins with policy incentives, and benefits from the expanded 45Z program. He also pointed to discipline in capital allocation, with 9M 2026 capital expenditures of $773 million and a lowered full-year capex outlook of $1.2 billion-$1.3 billion, plus $254 million returned as dividends and about $360 million of share repurchases. He said net leverage was 1.5x at quarter-end and reiterated selective bolt-on M&A and continued cost savings progress toward the $500 million-$750 million target.
Analysts focused on what could drive the EPS guide toward the top end, how management views 2027, and whether crush margins have peaked. Management said Q4 should still benefit from constructive biofuels margins, seasonal strength in Ag Services, and a partial reversal of mark-to-market impacts, while acknowledging seasonality in Flavors and ethanol and the possibility of market swings. On Nutrition, management said the one plant issue is being fixed and should not materially linger, while Animal Nutrition and Flavors remain strong. Questions also probed capex, 45Z, voluntary carbon credits, sweetener contracting, and policy durability; management responded that capex is being sequenced for best returns, the carbon-credit market is still nascent, sweetener negotiations are ongoing, and they do not expect a fundamental policy shift.
The call showed broad-based operational momentum, with especially strong profit growth in crushing, biodiesel, ethanol and Ag Services. Management also sounded increasingly confident about Nutrition, precision fermentation, and carbon capture as longer-term growth avenues, while 2027 was described as likely similar to 2026 with supportive biofuels demand and margins.
Nutrition still has some near-term issues, including a plant downtime/ramp-up, inflation in certain inputs, and seasonally weaker Flavors in Q4. Management also flagged ongoing uncertainty around mark-to-market impacts, volatile commodity and policy conditions, and softer liquid sweetener demand, while South American crush margins remain pressured by delays in Brazil biofuels policy changes.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.3%
- Shares Outstanding
- 475.92M
- Float Shares
- 472.62M
of shares held by institutions
1,218 13F filers
Buy/sell ratio 12.50. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for ADM, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Thomas Hawley TubervilleSenate · AL | Sell | Apr 15, 25 | Filing → |
| Gilbert CisnerosHouse · CA31 | Sell | Mar 20, 26 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Jan 29, 26 | Filing → |
| Thomas Hawley TubervilleSenate · AL | Sell | Apr 15, 25 | Filing → |
| Robert P. BresnahanHouse · PA08 | Buy | Apr 8, 25 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Sep 9, 24 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Mar 20, 24 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Mar 25, 24 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Feb 13, 24 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Feb 13, 24 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Jan 10, 24 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Nov 3, 23 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Aug 29, 23 | Filing → |
| Daniel GoldmanHouse · NY10 | Sell | Jul 12, 23 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 59.18M | ▲ 536.26K |
| State Farm Mutual Automobile Insurance Co | 46.80M | 0 |
| Blackrock, Inc. | 44.62M | ▲ 1.76M |
| State Street Corp | 31.60M | ▼ 2.04M |
| Vanguard Capital Management LLC | 31.49M | ▲ 251.07K |
| Vanguard Portfolio Management LLC | 26.92M | ▲ 875.23K |
| Wellington Management Group Llp | 17.67M | ▲ 382.46K |
| Charles Schwab Investment Management Inc | 16.62M | ▲ 1.31M |
| Sixth Street Partners Management Company, L.P. | 16.62M | ▲ 16.62M |
| Dodge & Cox | 14.18M | ▼ 1.57M |
| Geode Capital Management, LLC | 13.63M | ▲ 319.08K |
| Northern Trust Corp | 11.45M | ▼ 637.28K |
Held by 1,605 ETFs
Biggest fund positions in ADM by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 5, 26 | McAtee David R II | buy | 2,800 |
| Feb 5, 26 | McAtee David R II | buy | 7,500 |
| Oct 1, 26 | WESTBROOK KELVIN R | other | 721.591 |
| Oct 1, 26 | Schlitz Lei Zhang | other | 721.591 |
| Oct 1, 26 | Sandler Debra A. | other | 800.025 |
| Oct 1, 26 | MOORE PATRICK J | other | 721.591 |
| Oct 1, 26 | McMurray Michael C. | other | 721.591 |
| Oct 1, 26 | McAtee David R II | other | 721.591 |
| Oct 1, 26 | Harrison Suzan F. | other | 800.025 |
| Oct 1, 26 | de Brabander Ellen | other | 721.591 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ADM coverage
Recent articles, reports, and earnings notes.

Archer-Daniels-Midland (ADM): Earnings Recovery Drives a Buy
ADM looks attractive for moderate-risk investors as 2026 earnings recover sharply on stronger biofuels margins, export execution, and Nutrition improvement. The stock trades at a reasonable valuation versus its earnings rebound, with the report assigning a Buy and a B+ overall grade.

Archer-Daniels-Midland Company (ADM) drops after deep earnings
Archer-Daniels-Midland Company (ADM) beat EPS expectations and lifted guidance, but shares fell as revenue missed estimates and investors weighed the durability of margin gains. This deep-dive breaks down segment performance, cash generation concerns, and why strong profits still failed to support the stock.

Archer-Daniels-Midland Company (ADM) drops despite earnings beats
Archer-Daniels-Midland Company (ADM) drops 6.1% even after earnings beats, as investors react to the latest results and outlook.
Want a deeper read on ADM?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Safe-haven stocks dominate the risers as London traders go into risk-off mode
proactiveinvestors.com · Nov 20
ADM to Present at Goldman Sachs Industrials & Materials Conference 2026
businesswire.com · Nov 18
The Winners Inside SCHD - November 2026
seekingalpha.com · Nov 16
ADM Raises 2026 Earnings Outlook as Biofuel Strength Lifts Profit
zacks.com · Nov 16
Is ADM Stock Worth Buying as Earnings Improve but Key Risks Persist?
zacks.com · Nov 16
ADM Stock Falls 11.8% in the Past Month: Is the Pullback a Buy Now?
zacks.com · Nov 16
ADM Announces More Than $60 Million in Investments at Decatur Oilseed Facility
businesswire.com · Nov 16
Dividend Champion, Contender, And Challenger Highlights: Week Of November 15
seekingalpha.com · Nov 13
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
AI analysis · Last refreshed November 18, 2026 · Live quote · Not investment advice